ZimVie Announces First U.S. Surgery With The 4.5mm Mobi-C Cervical Disc
Portfolio Pulse from Benzinga Newsdesk
ZimVie Inc. (NASDAQ:ZIMV) announced the first U.S. surgery using the 4.5mm Mobi-C Cervical Disc. The smaller 4.5mm height Mobi-C implants were approved by the FDA in August 2023. The first implantation was performed by Gregory D. Lopez, M.D., at Midwest Orthopaedics at Rush in Chicago. ZimVie is also enrolling patients in the first ever cervical arthroplasty-fusion study in the U.S.
October 31, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ZimVie's successful first U.S. surgery with the 4.5mm Mobi-C Cervical Disc could potentially boost the company's reputation and market share in the spine market.
The successful first surgery with the 4.5mm Mobi-C Cervical Disc in the U.S. demonstrates ZimVie's ability to innovate and bring new products to market. This could potentially attract more customers and increase the company's market share in the spine market. Additionally, the company's ongoing enrollment in the first ever cervical arthroplasty-fusion study in the U.S. could further enhance its reputation and market position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100